Marshall Wace’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$216K Sell
2025
Q1
$914K Sell
2024
Q4
$3.6M Sell
2024
Q3
$5.67M Sell
2024
Q2
$5.5M Buy
2024
Q1
$4.27M Hold
2023
Q4
$2.94M Hold
2023
Q3
$5.71M Hold
2023
Q2
$7.74M Hold
2023
Q1
$7.58M Sell
2022
Q4
$14.1M Buy